Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
Tannock, I F, Osoba, D, Stockler, M R, Ernst, D S, Neville, A J, Moore, M J, Armitage, G R, Wilson, J J, Venner, P M, Coppin, C M, Murphy, K CVolume:
14
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.1996.14.6.1756
Date:
June, 1996
File:
PDF, 674 KB
english, 1996